Sigma-Aldrich Initiates RNAi Partnership Program
As part of the program, researchers at participating institutions will have early access to new technologies that are developed through Sigma- Aldrich's collaborations with TRC, Oxford BioMedica and Benitec. The partnership program will also facilitate collaborations with scientists at Sigma-Aldrich to validate current and emerging RNAi technologies.
Program participants will also benefit from a dedicated support team on Sigma's functional genomics product portfolio. This extensive product offering includes the Lentivirus-based MISSION(TM) TRC shRNA libraries, targeting more than 15,000 human and mouse genes, activated lentiviral particles, custom siRNA, and qPCR reagents.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.